NISA INVESTMENT ADVISORS, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q3 2021$2,000
-33.3%
5900.0%0.00%
Q2 2021$3,0000.0%5900.0%0.00%
Q1 2021$3,000
+50.0%
5900.0%0.00%
Q4 2020$2,0000.0%5900.0%0.00%
Q3 2020$2,000
-33.3%
5900.0%0.00%
Q2 2020$3,0000.0%590
-22.4%
0.00%
Q1 2020$3,0007600.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN 240,000$1,116,00099.38%
TANG CAPITAL MANAGEMENT LLC 9,607,934$44,677,0008.98%
HealthInvest Partners AB 830,000$3,860,0005.44%
RTW INVESTMENTS, LP 2,327,903$10,825,0000.16%
GLOBEFLEX CAPITAL L P 185,598$864,0000.09%
WealthTrust Axiom LLC 25,400$118,0000.04%
HOLLENCREST CAPITAL MANAGEMENT 82,355$383,0000.03%
FIRST MIDWEST BANK TRUST DIVISION 41,731$194,0000.02%
ACADIAN ASSET MANAGEMENT LLC 435,387$2,023,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 17,176$80,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders